Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 2
2015 2
2016 1
2017 4
2018 3
2019 1
2020 2
2021 8
2022 6
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis.
Schaupp L, Addante A, Völler M, Fentker K, Kuppe A, Bardua M, Duerr J, Piehler L, Röhmel J, Thee S, Kirchner M, Ziehm M, Lauster D, Haag R, Gradzielski M, Stahl M, Mertins P, Boutin S, Graeber SY, Mall MA. Schaupp L, et al. Among authors: graeber sy. Eur Respir J. 2023 Aug 3;62(2):2202153. doi: 10.1183/13993003.02153-2022. Print 2023 Aug. Eur Respir J. 2023. PMID: 37414422
Polyglycerol-Based Mucus-Inspired Hydrogels.
Sharma A, Thongrom B, Bhatia S, von Lospichl B, Addante A, Graeber SY, Lauster D, Mall MA, Gradzielski M, Haag R. Sharma A, et al. Among authors: graeber sy. Macromol Rapid Commun. 2021 Oct;42(20):e2100303. doi: 10.1002/marc.202100303. Epub 2021 Sep 13. Macromol Rapid Commun. 2021. PMID: 34418212
ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction.
Sermet-Gaudelus I, Girodon E, Vermeulen F, Solomon GM, Melotti P, Graeber SY, Bronsveld I, Rowe SM, Wilschanski M, Tümmler B, Cutting GR, Gonska T. Sermet-Gaudelus I, et al. Among authors: graeber sy. J Cyst Fibros. 2022 Nov;21(6):922-936. doi: 10.1016/j.jcf.2022.09.005. Epub 2022 Oct 5. J Cyst Fibros. 2022. PMID: 36207272
A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
Addante A, Raymond W, Gitlin I, Charbit A, Orain X, Scheffler AW, Kuppe A, Duerr J, Daniltchenko M, Drescher M, Graeber SY, Healy AM, Oscarson S, Fahy JV, Mall MA. Addante A, et al. Among authors: graeber sy. Eur Respir J. 2023 May 25;61(5):2202022. doi: 10.1183/13993003.02022-2022. Print 2023 May. Eur Respir J. 2023. PMID: 37080569 Free PMC article.
The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.
Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C, Mall MA. Zhou Z, et al. Among authors: graeber sy. J Cyst Fibros. 2011 Jun;10 Suppl 2:S172-82. doi: 10.1016/S1569-1993(11)60021-0. J Cyst Fibros. 2011. PMID: 21658636 Free article. Review.
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.
Graeber SY, Vitzthum C, Pallenberg ST, Naehrlich L, Stahl M, Rohrbach A, Drescher M, Minso R, Ringshausen FC, Rueckes-Nilges C, Klajda J, Berges J, Yu Y, Scheuermann H, Hirtz S, Sommerburg O, Dittrich AM, Tümmler B, Mall MA. Graeber SY, et al. Am J Respir Crit Care Med. 2022 Mar 1;205(5):540-549. doi: 10.1164/rccm.202110-2249OC. Am J Respir Crit Care Med. 2022. PMID: 34936849
42 results